Back to results
US 2026/0217711 A1Published application
Triazolopyridinyl ether linked compounds as kinase inhibitors
AssigneeBristol-Myers Squibb Company
InventorsGuanglin Luo, David B. Frennesson, Jeffrey Michael Schkeryantz, Jianliang Shi, Brian Lee Venables, Karin Irmgard Worm, Yong-Jin Wu, Murali T. G. Dhar
Life of this patent
Estimating the term…
Abstract
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Claims26
1-17. (canceled)
A compound having the structure
- or stereoisomer or salt thereof.
A compound having the structure
- or salt thereof.
A compound having the structure
A salt of a compound having the structure
Dependencies are inferred from the claim text.